PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cocrystal Pharma Inc | COCP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 1.50 | 0.00 | 0.00 | 0.00 | 1.50 | 07:00:07 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.27 | 6.50 | 5.23 | 80.46% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.00 | USD |
Cocrystal Pharma Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 47.43M | 31.62M | $ -49.05M | -1.75 | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Cocrystal Pharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/08/2019 | 09:15 | GlobeNewswire Inc. | Cocrystal Pharma Presents Data at the 26th International.. |
| 10/04/2019 | 08:31 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/01/2019 | 08:00 | GlobeNewswire Inc. | Cocrystal Pharma Announces Abstract Accepted for Poster.. |
| 9/26/2019 | 08:05 | GlobeNewswire Inc. | Cocrystal Pharma to Present at the 2019 Cantor Global.. |
| 9/03/2019 | 08:05 | GlobeNewswire Inc. | Cocrystal Pharma Presents Positive Preclinical Data for.. |
| 8/21/2019 | 08:05 | GlobeNewswire Inc. | Cocrystal Pharma Announces Abstract Accepted for Oral.. |
| 6/25/2019 | 08:31 | Edgar (US Regulatory) | Current Report Filing (8-k) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical COCP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.04 | 2.08 | 1.31 | 1.4829 | 20k | -0.54 | -26.47% |
| 1 Month | 1.83 | 2.29 | 1.31 | 1.7239 | 9k | -0.33 | -18.03% |
| 3 Months | 2.0101 | 2.95 | 1.31 | 1.9549 | 7k | -0.5101 | -25.38% |
| 6 Months | 2.6633 | 2.95 | 1.31 | 2.2191 | 8k | -1.1633 | -43.68% |
| 1 Year | 2.7 | 5.4 | 1.31 | 2.8697 | 23k | -1.2 | -44.44% |
| 3 Years | 4.36 | 6.45 | 1.31 | 3.0019 | 41k | -2.86 | -65.60% |
| 5 Years | 4.36 | 6.45 | 1.31 | 3.0019 | 41k | -2.86 | -65.60% |
Cocrystal Pharma Description
| Cocrystal Pharma Inc is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). CC-31244 is currently being evaluated in a Phase 2a study for the treatment of hepatitis C as part of a cocktail for ultra-short therapy of 4 to 6 weeks. |
